There are two main types of lung cancer: small cell and non-small cell. According to the American Cancer Society, non-small ...

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

For patients with stage IA non-small cell lung cancer (NSCLC), lung resections, including lobectomy and segmentectomy, are ...

Trilaciclib significantly reduced chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer, which ...

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

Chavez, MD, discusses how comprehensive genomic profiling may impact the treatment and clinical management of patients with small cell lung cancer.

Obesity was associated with improved overall survival (OS) after curative resection in patients with non-small cell lung cancer (NSCLC), particularly those who did not have low sk ...

Cullinan Therapeutics has announced that its lead asset has aced a midstage lung cancer trial—but the biotech is keeping the ...

For early-stage NSCLC, lobar resection has been the gold standard since 1995 with publication of the LCSG trial. Given that ...

During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.

rare type of small cell lung cancer that primarily affects younger people who have never ... Aug. 23, 2024 — A team of researchers has created a digital pathology platform based on artificial ...

Susan Galbraith, Executive Vice President, Oncology R&D, AstraZeneca, said: "Acquired resistance to front-line therapies and, ultimately, disease progression are unfortunate realities for most ...